C Rad AB OMXSTO:CRAD_B:
STRENGTHENS CZECH PRESENCE WITH A STRATEGICALLY IMPORTANT ORDER FROM KRAJSKÁ NEMOCNICE HOSPITAL IN LIBEREC.
RECEIVES 10 MSEK ORDER FROM CZECH HOSPITAL
C-Rad Wins Order From From Czech Hospital
Watch C-Rad's latest callC-Rad (Stockholm:CRAD B) Q4 2025 Earnings Call · Replay · Feb 12Read the transcript of C-Rad (Stockholm:CRAD B) Q4 2025 Earnings CallEarlier from C-Rad
- CRAD_B: Order intake up 11%, service orders up 86%, but revenue down 13% year-on-year
- CRAD_B: Order intake up 5% and revenue up 1% YoY, with strong APAC and EMEA performance
- CRAD_B: Q4 EBIT up 77% and APAC revenue up 112%, highlighting strong profitability and growth
- CRAD_B: Profitability held firm with improved margins, despite lower orders and EMEA weakness
- CRAD_B: Q2 revenue surged 43% and margins improved, driven by strong APAC and Americas growth
Later from C-Rad
- C-RAD AB: Quarterly Trading Report 2025 Q3
- C-RAD Q3 EBIT Up At SEK 21.2 Mln
- CRAD_B: Q3 saw 12% revenue growth, 19% EBIT margin, and strong Services, with EMEA leading gains
- C-RAD Appoints Tomas Blomquist As CEO
- Invitation to presentation of C-RAD’s year-end report and report for the fourth quarter 2025
Follow C-Rad into a list and get an email when it puts out news.
Follow C-Rad